CD79A and viral infectious disease: On the other hand, serum IgA from some HIV-1-infected individuals has been reported to exhibit antibody-dependent enhancement of viral infection (Kozlowski et al., 1995), and the plasma IgA response to HIV-1 Env has been associated with increased risk of HIV-1 acquisition in the RV144 vaccine trial (Haynes et al., 2012).